ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
Saptak Chem and Business Limited held its 47th Annual General Meeting on August 29, 2026, via video conferencing. Shareholders transacted ordinary and special business items during the meeting.
Saptak Chem and Business Limited issued a corrigendum to its 47th AGM notice, rescheduling the meeting to August 29, 2026, and updating director appointment dates.
Saptak Chem and Business Limited has submitted its 47th Annual Report for the financial year 2025-26 to the BSE. The report is now available for shareholder reference.
Saptak Chem and Business Limited issued notice for its 47th Annual General Meeting, scheduled for August 28, 2026, via video conferencing.
Saptak Chem filed its quarterly Statement of Deviation/Variation regarding funds raised via preferential issue, confirming no deviation in the utilization of proceeds.
Saptak Chem And Business Ltd reported net profit of ₹0 Cr for Q1 FY27.
Saptak Chem and Business Limited will hold a board meeting on August 1, 2026, to consider quarterly unaudited financial results and the appointment of a Managing Director.
Saptak Chem announced the resignation of Mr. Ajay Suresh Yadav from the company's Board of Directors, effective July 07, 2026.
Saptak Chem And Business Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The report details the distribution of shares across promoter and public categories.
Saptak Chem and Business Ltd approved shifting its registered office. The move is from Naranpura to Vejalpur Road in Ahmedabad.
Saptak Chem and Business Ltd confirmed zero deviation in utilizing ₹1.05 Crore raised via preferential warrants. The funds were fully deployed for working capital requirements.
Saptak Chem And Business Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
Saptak Chem and Business Limited reported its audited financial results for the fiscal year ended March 31, 2026. The company recorded a net loss of ₹30.21 Lakhs.
Saptak Chem and Business scheduled a board meeting on May 14, 2026. The board will approve audited financial results for fiscal year 2026.
Saptak Chem and Business Limited confirmed it does not fall under the SEBI 'Large Corporate' criteria for the financial year. The company reported zero outstanding borrowings as of March 31, exempting it from specific debt-raising disclosure requirements.
Saptak Chem And Business Ltd reported a net loss of ₹0.1 Cr for Q3 FY26.
HMM Consultancy LLP acquired 5,00,000 equity shares of Saptak Chem And Business Limited on April 6, 2026. This acquisition represents a 9.86% stake in the target company's diluted share capital. The acquirer is a non-promoter entity, and the transaction was conducted via a preferential allotment.
Akshay Shah HUF acquired 5,00,000 equity shares of Saptak Chem And Business Limited on April 6, 2026. This acquisition represents 9.86% of the company's total diluted share capital. The acquirer is a non-promoter entity, and the transaction was conducted via a preferential allotment.
Ankush Agarwal HUF acquired 5,00,000 equity shares in Saptak Chem And Business Ltd through a preferential allotment on April 6, 2026. This acquisition represents 16.27% of the company's pre-issue capital and 9.86% of the post-issue diluted capital.
Jayshree Jain acquired 5,00,000 equity shares of Saptak Chem And Business Limited via preferential allotment on April 6, 2026. This acquisition represents 9.86% of the company's total diluted share capital. The transaction was disclosed under SEBI (SAST) Regulations, 2011.
Saptak Chem and Business Ltd submitted a compliance certificate for the quarter ended March 31, 2026, regarding Regulation 74(5) of SEBI Regulations. The filing confirms that securities received for dematerialisation were processed, certificates cancelled, and the depository's name substituted in the company's records.
Saptak Chem and Business Ltd allotted 20,00,000 equity shares to four non-promoter investors upon the conversion of warrants. The company received Rs. 1.58 Crore (75% balance) for this conversion, increasing its paid-up capital to Rs. 3.07 Crore.